Yes, the FDA has approved Veklury (remdesivir) for certain COVID-19 patients.
What is the first drug that was approved by the FDA to treat COVID-19?
Remdesivir is the first drug approved by the FDA for treatment of hospitalized COVID patients over the age of 12.
What is the difference between PCR and antigen test?
Rapid, accurate tests are essential to contain a highly contagious virus like SARS-CoV-2. PCR tests are accurate but can take a long time to produce results. Antigen tests, the other major type of coronavirus test, while much faster, are less accurate.
Is the PCR test for COVID-19 accurate?
PCR tests remain the gold standard for detecting an active COVID-19 infection. The tests have accurately detected COVID-19 cases since the pandemic began. Highly trained clinical professionals are skilled at correctly interpreting PCR test results and notices like this one from the WHO.
For which COVID-19 patients has been approved Remdesivir?
On October 22, 2020, the FDA approved the antiviral drug Veklury (remdesivir) for use in adults and pediatric patients (12 years of age and older and weighing at least 40 kg) for the treatment of COVID-19 requiring hospitalization.
What treatments are available for COVID-19?
What is Remdesivir?
Remdesivir is in a class of medications called antivirals. It works by stopping the virus from spreading in the body.
How can you detect COVID-19 from a PCR test?
This can be a nasal swab or a bit of saliva. For PCR tests, the next step is amplification of genetic material so that even a small amount of coronavirus genes in the patient’s sample can be detected. This is done using a technique called a polymerase chain reaction.
Is Remdesivir used in treating COVID-19?
Conclusions: Remdesivir can help improve the clinical outcome of hospitalized patients with COVID-19 and a 5 day regimen, instead of a 10 day regimen, may be sufficient for treatment. Moreover, remdesivir appears as tolerable as other comparators or placebo.
